Mount Hope Mining has hit more strong gold in Phase 2 drilling at Mt Solitary, growing the footprint and showing there’s ...

After the FDA placed two of its next-gen HIV drugs on clinical hold last June, Gilead Sciences has now terminated one of the ...

Alkermes announced today the initiation of the Brilliance Studies, a phase 3 program that will test the safety and efficacy of alixorexton compared with placebo in adults, according to a news release.

¹ Initial assay results for PL-111 and PL-112 were previously reported on March 2, 2026.

United Therapeutics Corporation Strong Buy: phase 3 Tyvaso wins in IPF boost FVC, support summer sNDA and Priority Review ...

In early 2026, Mitolyn reviews have moved far beyond curiosity and into serious comparison as new mitochondrial research finally explains why so many disciplined adults over 30 hit unbreakable ...

NASA's Artemis II astronauts launched on a nine-and-a-half-day mission around the moon and back. The rocket lifted off ...

The destruction of a U.S. Air Force E-3G Sentry AWACS in Saudi Arabia has reignited debate about the procurement of the E-7A ...

How LLM agents present AI software engineering workflows of the future, and whether the focus of programming will shift from ...

Artemis II is scheduled to launch from Launch Pad 39B at Kennedy Space Center in Florida on Wednesday, sending four ...

Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF)(Frankfurt:SC1P) ('Skyharbour” or the 'Company”) is pleased to announce ...

White House AI power pledge drives shift toward microgrids; GenerMotor’s single‑conversion native DC offers AI server ...